Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 26859106.
- Also identified by DOI 10.1210/jc.2015-4181 and PMC identifier 4880160.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We compared effects of teriparatide and denosumab on PTH, bone turnover markers, and bone histomorphometry in osteoporotic postmenopausal women. The findings were inconsistent with an early indirect anabolic effect of denosumab.
Medical subject headings
- Bone Density Conservation Agents
- Denosumab
- Osteogenesis
- Osteoporosis, Postmenopausal
- Parathyroid Hormone
- Teriparatide